Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Jasper Therapeutics, Inc. - Class A Common Stock (NQ: JSPR )

6.690 -0.360 (-5.11%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,121,673
Open 6.880
Bid (Size) 6.510 (1)
Ask (Size) 6.790 (1)
Prev. Close 7.050
Today's Range 6.300 - 6.990
52wk Range 6.300 - 31.01
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Crude Oil Down 1%; US Weekly Jobless Claims Decline
Via Benzinga
Exposures Fossil Fuels

Performance

YTD
-68.28%
-68.28%
1 Month
-67.52%
-67.52%
3 Month
-59.65%
-59.65%
6 Month
-66.42%
-66.42%
1 Year
-25.25%
-25.25%

More News

Read More
Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors
Via Benzinga
US Stocks Down; Acuity Brands Posts Weak Revenue
Via Benzinga
Futures Slump As Yields, Dollar Soar
Via Talk Markets
Topics Commodities Stocks / Equities
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q4 2023
Via InvestorPlace
Jasper Therapeutics: Q3 Earnings Insights
Via Benzinga
Where Jasper Therapeutics Stands With Analysts
Via Benzinga
Why Is Chronic Disease-Focused Jasper Therapeutics Stock Trading Higher On Monday?
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q2 2024
Via InvestorPlace
JSPR Stock Earnings: Jasper Therapeutics Beats EPS for Q1 2024
Via InvestorPlace
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
Via Benzinga
Over $15M Bet On Aon? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Jasper Therapeutics, Inc.
Via GlobeNewswire
Jasper Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
From Jasper Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
From Jasper Therapeutics, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Via Benzinga
Gilead Boosts Biotech Footprint With Stakes In AlloVir And Arcus
Via MarketBeat
Topics Retirement
Exposures Pension
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.